Download The 2025 SfN Post-Conference Report
The SFN 2025 post-conference report will help neuroscience drug developers quickly understand the key drug development trends emerging from SfN 2025, while also providing a single, streamlined location to easily review the abstracts most relevant to the neurological drug development landscape.
The Report Includes:
The analysis and summary of the 46 neurological drug and trial focused abstracts presented at SFN 2025.
- Abstract Analysis: A breakdown of abstracts by neuroscience disease indication and therapeutic class, as well as a focused look at repurposing existing clinically approved drugs for new neurological disease indications.
- Abstract Summaries: Easy to review abstract summaries, including disease indication, therapeutic class, sponsor, abstract ID, and links to the full abstract on the SfN website
You May Also Be Interested In…
Learn More About Neuroscience
- The Most Comprehensive Way to Search the Neuroscience Drug Development Landscape: Unique search ontologies based on Neuroscience drug and trial characteristics
- Market Leading Approach to Neuroscience Preclinical & Clinical Data Curation: Manual curation of key Neuroscience research and development data points by Neuroscience research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Neuroscience company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
